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Abstract
Background: C57BL/6 mice have attenuated allergic airway hyperresponsiveness (AHR) when
compared with Balb/c mice but the underlying mechanisms remain unclear. SP-D, an innate immune
molecule with potent immunosuppressive activities may have an important modulatory role in the
allergic airway response and the consequent physiological changes. We hypothesized that an
elevated SP-D production is associated with the impaired ability of C57BL/6 mice to develop
allergic AHR.
Methods: SP-D mRNA and protein expression was investigated during development of allergic
airway changes in a model of Aspergillus fumigatus (Af)-induced allergic inflammation. To study
whether strain dependency of allergic AHR is associated with different levels of SP-D in the lung,
Balb/c and C57BL/6 mice were compared.
Results: Sensitization and exposure to Af induced significant airway inflammation in both mouse
strains in comparison with naïve controls. AHR to acetylcholine however was significantly
attenuated in C57BL/6 mice in spite of increased eosinophilia and serum IgE when compared with
Balb/c mice (p < 0.05). Af challenge of sensitized C57BL/6 mice induced a markedly increased SP-
D protein expression in the SA surfactant fraction (1,894 ± 170% of naïve controls) that was 1.5
fold greater than the increase in Balb/c mice (1,234 ± 121% p < 0.01). These changes were selective
since levels of the hydrophobic SP-B and SP-C and the hydrophilic SP-A were significantly
decreased following sensitization and challenge with Af in both strains. Further, sensitized and
exposed C57BL/6 mice had significantly lower IL-4 and IL-5 in the BAL fluid than that of Balb/c mice
(p < 0.05).
Conclusions: These results suggest that enhanced SP-D production in the lung of C57BL/6 mice
may contribute to an attenuated AHR in response to allergic airway sensitization. SP-D may act by
inhibiting synthesis of Th2 cytokines.
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Background
Airway hyperresponsiveness (AHR) is a heritable poly-
genic trait and together with eosinophilic airway inflam-
mation and IgE production, is a hallmark of human
allergic asthma. Demonstration of strain differences in
susceptibility to develop AHR to allergic sensitization has
long been intriguing and promoted the use of inbred
mouse strains for the investigation of genetic determi-
nants of allergic AHR (reviewed by Heinzmann and
Daser, [1]). C57BL/6 mice are relatively hyporesponsive
to non-specific airway stimuli and resistant to develop-
ment of allergic AHR in comparison with a number of
other inbred mouse strains [2-4]. Although the exact
mechanisms that determine susceptibility or resistance to
develop allergic AHR remain unclear, airway inflamma-
tion and the underlying adaptive immune responses are
thought to play a major role [5-10].
The role of T cell dependent (adaptive) allergic inflamma-
tion is well established in the pathogenesis of asthma [6-
8,10,11]. However, the modulatory function that the
innate immune system plays during allergic sensitization
remains less understood. We have recently described that
expression of an innate immune molecule, surfactant pro-
tein (SP)-D was significantly increased during allergic
inflammatory changes in the lung in a murine model [12].
This soluble pattern recognition receptor (also termed
lung collectin that consists of a collagenous and a lectin-
like motif) may play a regulatory role in the allergic airway
changes although its exact mechanism of action is
unknown [13].
In this study we examined the differences in allergic air-
way hyperresponsiveness between C57BL/6 and Balb/c
mice and associated changes in surfactant component
expression using age-and sex matched C57BL/6 and Balb/
c mice in a model of Aspergillus fumigatus induced allergic
AHR. Our results demonstrate an inverse relationship
between the ability to develop allergen induced AHR and
the extent of SP-D production.
Methods
Mice, sensitization and intranasal challenge with 
Aspergillus fumigatus (Af)-extract
To study the relationship between the ability to produce
SP-D and develop AHR, a model of Af-induced allergic
sensitization was characterized in two inbred mouse
strains. Female BALB/c and C57BL/6 mice were housed
under pathogen-free conditions. Experiments were per-
formed between 8–12 weeks of age. All experimental ani-
mals used in this study were under a protocol approved by
the Institutional Animal Care and Use Committee of the
University of Pennsylvania. Two groups of the mouse
strains were compared: "Naive" mice received intranasal
vehicle challenges with 21% glycerol in PBS. "Sensitized"
mice were injected intraperitoneally (i.p.) with 20 µg of Af
(Bayer Pharmaceuticals, Elkhart, IN) together with 20 mg
Al(OH)3 (Imject Alum; Pierce, Rockford, IL) in PBS (100
µl) on days 1 and 14, followed by intranasal challenge
(i.n.) on days 25, 26, and 27 with 25 µl of allergen extract:
(12.5 µg Af in 21% glycerol/ PBS). Limulus lysate assay
(Limulus  Amebocyte Lysate QCL-1000; Bio-Whittaker)
was used to determine the endotoxin content in the aller-
genic Af extract. We have found that LPS level was 1.22 pg
LPS/µg protein in the Af extract we used to sensitize mice
in this study. The weight range of the groups of mice were
the following: Balb/c Naïve: 21–30 g (n = 15); Balb/c Sen-
sitized: 20–30 (n = 22); C57BL/6 Naïve: 22–29 (n = 17);
C57BL/6 Sensitized: 22–29 (n = 22). Intranasal treatment
was carried out essentially as described previously
[12,14,15]. Briefly, sensitized and control mice were anes-
thetized by isoflurane inhalation, and 25 µl of Af extract
or vehicle was applied to the left nares respectively. The
studies were performed and all mice were sacrificed 24
hour after their last intranasal treatment, when the peaks
of eosinophil infiltration and airway responses were
assumed to occur. Naïve mice that received intranasal
glycerol treatment alone showed no difference from non
sensitized, non exposed normal BALB/c and C57BL-6
mice in any of the study parameters that we investigated,
including lung histology, BAL cellular content, immu-
noglobulin and cytokine profile and airway responses to
acetylcholine (not shown).
In vivo measurement of airway responsiveness to 
acetylcholine (ACh)
Airway function measurements were carried out as previ-
ously described [12]. Briefly, anesthesia was provided by
intra-peritoneal administration of a mixture of ketamine
(100 mg/kg) and xylazine (20 mg/kg), every 20 minutes
before and during all surgical procedures. Mice were can-
ulated, and ventilated (140 breaths/min; 0.2 ml tidal vol-
ume) following administration of pancuronium bromide
(1.0 mg/kg). Transduced alveolar pressure and airflow
rate (Validyne DP45 and DP103, USA) was used to calcu-
late lung resistance (RL) and dynamic compliance (Cdyn)
by a computer (Buxco Electronics, Inc. NY). Baseline RL
and Cdyn values were established and after administration
of saline, ACh was given intravenously at concentrations
ranging from 80 to 1280 µg/kg in five increments.
Serum ELISA for Immunoglobulins
To detect levels of sensitization and to compare C57BL/6
and Balb/c mice, serum samples were collected as
described before [12,16,17]. Antibodies and recombinant
IgE were purchased from PharMingen (San Diego CA)
and antibody levels were determined according to instruc-
tions of the manufacturer. For Af-specific antibody levels
plates (Dynatech, Chantilly, VA) were coated with Af (50
µg/ml in PBS, pH 7.1), incubated overnight at 4°C.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/15
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Samples were diluted 1:5 for Af specific IgE and IgG2a,
and 1:25 for IgG1 and for total IgE. Data were analyzed
with the Microplate Manager software program for the PC
version (Bio-Rad, Hercules, CA).
BAL analysis for differential cell count, cytokine and 
surfactant content
Lungs were lavaged using either a small volume (1 ml ster-
ile PBS for the analysis of the BAL cytokine profile) or a
large volume (5 ml of sterile saline for analysis of the sur-
factant protein profile). The amount of liquid retained
after BAL was an average of 0.75 ml when 1 ml lavage was
used and 4.5 ml when 5 ml lavage was used. Total and dif-
ferential cell counts were performed as described previ-
ously [12,16,17]. Cytokine levels were determined from
cell free supernatant of the small volume BAL by ELISA
using antibodies and recombinant cytokines from
PharMingen, (San Diego, CA). ELISA analysis was per-
formed as previously described [12,16,17] and cytokine
levels were expressed as pg/µg of total protein. Cell free
supernatant of the large volume BAL was separated into
large-aggregate (LA) and small-aggregate (SA) fractions by
differential centrifugation as described previously [18,19].
Total protein and phospholipid contents of the LA and SA
fractions were determined using standard methods. SDS-
PAGE of LA and SA surfactant samples was carried out
using NuPAGE 10% Bis-Tris gels (Novex, San Diego, CA)
according to instructions of the manufacturer. Western
blots were performed as previously described [18,19]
using anti-SP-C from Byk Goulden Pharmaceuticals (Con-
stance, Germany), monospecific, polyclonal surfactant
protein antisera against SP-A, SP-B and SP-D were pro-
duced in rabbits using purified rat SP-A, bovine SP-B, and
recombinant mouse SP-D as previously described [18,19].
Analysis of mRNA expression
Total RNA was isolated from lungs after BAL as described
before [18,19]. Specific mRNA content was determined by
Northern blot analysis. Nitrocellulose blots with total
RNA were hybridized under high stringency with [α-
32P]cDNA probes for rat SP-A, SP-B, SP-C and SP-D pre-
pared from purified plasmid inserts by labeling with [α-
32P]dCTP (Ready-to-Go Kit, Pharmacia, Piscataway, NJ) to
specific activities of 6–8 × 106 counts/min/µg DNA as pre-
viously described (1, 2). The specific signals were normal-
ized for loading by hybridization of each blot with an 32P
end-labeled ([γ-32P]ATP) 28S rRNA oligonucleotide
probe. Specific mRNA bands were quantified by Phos-
phoimager (Biorad, Hercules, CA).
SP-A ELISA
In order to analyze and compare the SP-A content in the
SA surfactant fractions, in addition to Western blot analy-
sis, we have developed an ELISA protocol using a com-
mercially available kit (Vectastain 6100 kit, Vector
Laboratories, Burlingame, CA). Aliquots of SA samples
neat or diluted 1:2 with blocking buffer (1% FBS in Dul-
becco's PBS) were applied to 96-well Nunc-Immuno Max-
iSorp plates (Nalge Nunc International, Denmark). Each
assay plate included a standard of human purified SP-A
from the BAL fluid of patients suffering from alveolar pro-
teinosis (1 to 2700 ng/well). Polyclonal anti-SP-A antise-
rum (PA3) was applied as a primary antibody (1:50,000)
with goat anti-rabbit IgG (1:1000) as the secondary anti-
body (Vectastain kit 6101, Vector Laboratories). Colori-
metric detection of antibody binding was performed
according to the manufacturer's instructions using TMB
(TMB Substrate Reagent Set, BD PharMingen) as sub-
strate. Color intensity was measured at 405 nm using an
automated microplate reader (Bio-Rad, Hercules, CA) and
analyzed with Bio-Rad Microplate Manager software, PC
version 5.0.1. Values for unknown samples falling within
the linear range of the standard curve were used to obtain
the total SP-A content of each sample.
Data analysis
Data were expressed as mean ± SEM. ANOVA or Student's
t test assuming equal variances were performed to test dif-
ferences between groups. A p value of <0.05 was consid-
ered as significant. Data were analyzed with the Sigmastat
standard statistical package (Jandel Scientific).
Results and discussion
Allergen challenge of sensitized C57BL/6 mice induced 
attenuated airway hyperresponsiveness to ACh in 
comparison with Balb/c mice
To compare the effects of antigenic sensitization between
C57BL/6 and Balb/c mice, we used an established model
of i.p. sensitization and i.n. provocation with an extract of
Af that elicited significant increases in airway responses to
non-specific stimuli such as ACh [12,14-16]. Following
i.p. sensitization and i.n. challenges with Af, as expected
on the basis of our previous findings, significant increases
in allergic AHR occurred in both the C57BL/6 and Balb/c
mice. We confirmed increases in airway obstruction by
measuring lung resistance (RL, Fig 1A) and by measuring
changes in the dynamic compliance (Cdyn, Fig 1B) [20].
Mice sensitized and exposed to Af  showed significant
increases in lung resistance (RL) and decreases in dynamic
compliance (Cdyn) in a dose-dependent manner in
response to ACh when compared with naïve controls in
both the Balb/c and C57BL/6 groups (ANOVA p < 0.001
and p < 0.01, respectively). However, the changes in both
RL(655 ± 202% maximal increase over the baseline) and
Cdyn (a decrease to 59.3 ± 8.8% of the original baseline)
were significantly greater in sensitized Balb/c mice com-
pared with those in C57BL/6 mice (RL: 297 ± 93% maxi-
mal increase over the baseline and Cdyn: a decrease to
79.3 ± 7.5% of the baseline) (p < 0.05, ANOVA). Baseline
airway function was also examined in each mouse strainsRespiratory Research 2003, 4 http://respiratory-research.com/content/4/1/15
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before ACh administration. There were no significant dif-
ferences in baseline RL or Cdyn between mouse strains (not
shown). Thus, along with a number of different models
[2-4], our results demonstrated an attenuated AHR in
C57BL/6 mice to non-specific airway stimuli suggesting
genetically determined underlying mechanisms.
C57BL/6 mice developed significant systemic IgE and IgG1 
levels following allergenic sensitization and challenge with 
Af, comparable to the responses of Balb/c mice
Allergic AHR occurs through a variety of pathogenic
mechanisms depending on the genetic background of the
animal and the type of immunization [1,4,21]. Interest-
ingly, the elicited airway inflammation and IgE produc-
tion may dissociate from the measures of airway
obstruction [1,3,4,21-25]. To investigate whether C57BL/
Allergen challenge of sensitized C57BL/6 mice induced a significantly attenuated airway hyperresponsiveness to ACh in com- parison with Balb/c mice Figure 1
Allergen challenge of sensitized C57BL/6 mice induced a significantly attenuated airway hyperresponsiveness 
to ACh in comparison with Balb/c mice. Mice were sensitized and exposed to Af and their lung function was assessed by 
measuring Lung Resistance (RL, panel A) and Dynamic Compliance (Cdyn, panel B) by a BUXCO online system as described. RL 
and Cdyn values were obtained in response to increasing concentrations of intravenous (i.v.) ACh in both strains of mice. Data 
are expressed as % changes from baseline. The Naïve group (open square, C57BL/6 or open circle, Balb/c) received intranasal 
glycerol treatment alone. The Sensitized group (closed squares, C57BL/6 or closed circle, Balb/c) received intraperitoneal (i.p.) 
sensitization and intranasal (i.n.) challenge with Af extract as described. Baseline RL values in the Naïve and in the Sensitized 
groups were 0.84 ± 0.04 and 1.25 ± 0.11 Hgmm/cmH2O/min respectively, in the C57BL/6 mice and 1.26 ± 0.03 and 1.48 ± 0.06 
Hgmm/cmH2O/min, respectively in the Balb/c mice. Results are expressed as Mean ± SEM of n = 6–7. ANOVA was used to 
compare the dose response curves followed by Student's t test for comparisons between individual data points. *p < 0.05 Sen-
sitized vs Naive; #p < 0.05 C57BL/6 vs Balb/c.
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6 mice produce total and Af specific serum IgE and IgG at
a comparable level to that of Balb/c mice, we analyzed
total serum IgE together with the Af-specific immunoglob-
ulin profile (IgE, IgG1 and IgG2a). Mice were sensitized
and challenged with Af and blood obtained 24 h after the
last allergen challenge. Similarly to our previous findings
[12,17], Af sensitization resulted in markedly increased
serum IgE, IgG1 and IgG2a levels. As shown in Figure 2A,
C57BL/6 mice were not deficient in producing these
immunoglobulins upon systemic sensitization and chal-
lenges; in fact, levels of total serum IgE (Fig 2A; p < 0.05)
and Af-specific IgG1 (Fig 2B; p < 0.01) were significantly
greater in this strain than in Balb/c mice. There were no
significant differences between the levels of Af-specific IgE
(Fig 2C) and IgG2a (not shown) between the two mouse
strains. These data suggest that C57BL/6 mice are not
impaired in their capability to develop systemic allergic
response upon sensitization with Af in our model. Thus,
along with Zhang and colleagues [4] and Takeda and col-
leagues [3] we show that a decreased airway responsive-
ness in C57BL/6 mice is not accompanied by similar
reduction in the total and antigen-specific IgE and IgG1
levels.
C57BL/6 mice developed significant systemic IgE and IgG1 responses following allergenic sensitization and challenge with Af  comparable to the responses of Balb/c mice Figure 2
C57BL/6 mice developed significant systemic IgE and IgG1 responses following allergenic sensitization and 
challenge with Af comparable to the responses of Balb/c mice. Total serum IgE and Af-specific IgE and IgG1 profiles 
were analyzed by ELISA as described. Total serum IgE (panel A): expressed as ng/ml. Af-specific IgG1 and IgE (panel B and C) 
expressed as optical density (O.D.). Naïve mice (open bar: Balb/c (n = 15); light gray bar: C57BL/6 (n = 17)) received i.n. glyc-
erol treatment alone. Sensitized mice (black bars: Balb/c (n = 22); dark gray bar: C57BL/6 (n = 22)) received i.p. sensitization 
and i.n. treatment with Af extract as described. Data are expressed as Mean ± SEM, *p < 0.05 Sensitized vs Naive; #p < 0.05 
C57BL/6 vs Balb/c.
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C57BL/6 mice develop local airway inflammatory response 
after i.n. challenge of sensitized mice
Although the number of eosinophils recovered from the
BAL fluid of asthmatic patients (reviewed in [6]) and in
mouse models of asthma [3,22,23] roughly correlates
with disease severity, eosinophil numbers may not
directly relate to the extent of airway responsiveness or tis-
sue injury. Hematoxilyn eosin staining of histological
lung section from both Balb/c and C57BL/6 mice that
were sensitized and challenged with Af demonstrated a
predominantly perivascular and peribronchial inflamma-
tory infiltrate of mainly mononuclear cells and eosi-
nophils, (data not shown) as previously described [3].
Analysis of the cellular fraction of BAL showed that both
Balb/c and C57BL/6 mice had increased and similar total
cell numbers after sensitization and challenge with Af
(Figure 3A) in comparison with naïve controls. In spite of
a comparable total BAL cell count between Balb/c and
C57BL/6 mice however, the numbers of eosinophils were
significantly higher in sensitized C57BL/6 mice than sen-
sitized Balb/c mice (609 ± 90 × 103 vs 140 ± 42 × 103,
respectively, p < 0.001), (Figure 3B).
In order to compare the effects of allergic sensitization
and challenge on phospholipid and protein content of the
BAL between Balb/c and C57BL/6 mice, we next examined
the large aggregate (LA) and small aggregate (SA) sur-
factant fractions of the cell free BAL supernatant as
Upon allergen challenge, sensitized C57BL/6 mice developed significantly augmented airway eosinophilia when compared with  Balb/c mice Figure 3
Upon allergen challenge, sensitized C57BL/6 mice developed significantly augmented airway eosinophilia 
when compared with Balb/c mice. The absolute number of BAL cells (panel B) was derived from the differential counts in 
Giemsa-stained cytospin preparations and the total cell counts (panel A) in each BAL sample as described. Naïve mice (open 
bar: Balb/c (n = 15); light gray bar: C57BL/6 (n = 17)) received i.n. glycerol treatment alone. Sensitized mice (black bars: Balb/c 
(n = 22); dark gray bar: C57BL/6 (n = 22)) received i.p. sensitization and i.n. treatment with Af extract as described. Data are 
expressed as Mean ± SEM, *p < 0.05 Sensitized vs Naive; #p < 0.05 C57BL/6 vs Balb/c.
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described previously [26,27] (Table 1). Sensitization and
challenge induced a 2-fold increase in protein levels in the
SA fraction (where the majority of protein is found; p <
0.01) and a conversion of phospholipids between the LA
and the SA (p < 0.05) surfactant fraction in C57BL/6 (but
not Balb/c mice). Thus, analysis of the BAL cellular, pro-
tein and phospholipid profile indicated that C57BL/6
mice are capable of developing local inflammatory
changes comparable and indeed more prominent than
those in Balb/c mice upon allergic sensitization and
challenge.
C57BL/6 mice had markedly elevated SP-D levels both at 
baseline and after sensitization and challenge with Af in 
comparison with Balb/c mice
We have previously shown that allergic Th2-type inflam-
mation induced production of SP-D, an otherwise consti-
tutively expressed protein in the lung [12]. These studies
were recently confirmed by others in murine models [28]
and in human asthmatic patients [29]. Increases in SP-D
expression in lung inflammation have been also described
in our laboratory in a different model of inflammation
induced by Pneumocystis carinii pneumonia [18,19]. In
contrast to the non-specific upregulation of both
hydrophilic surfactant proteins SP-A and SP-D in pneu-
monia however, allergic airway inflammation selectively
affected SP-D production, suggesting distinct regulatory
pathways and a specific role for this lung collectin [12].
We analyzed whether the changes induced by allergic sen-
sitization and challenge with Af in pulmonary surfactant
protein expression were different between C57BL/6 and
Balb/c mice. Cell free supernatant of BAL was further frac-
tionated into large (LA) and small (SA) aggregate sur-
factant fractions by differential centrifugation as described
previously in our laboratory [18,19]. Fractionation of the
BAL is important because of the differential surfactant
protein profile that may be recovered from the different
fractions: while the majority of the proteinaceous material
and SP-D can be found in the SA, most of the phospholi-
pids and all of the hydrophobic surfactant proteins (SP-B
and C) are in the LA fraction. Analyses of the BAL cell pel-
let for SP-D expression showed no significant differences
among the groups (not shown) suggesting that cell-asso-
ciated SP-D does not represent a significant proportion of
collectins in this model. Immunoblot analysis demon-
strated that Af  challenge of sensitized C57BL/6 mice
induced increased SP-D protein expression in the LA sur-
factant fraction (352 ± 88% of the naïve control levels)
that was 1.6 fold greater than in Balb/c mice (221 ± 36%,
p < 0.05). In the SA surfactant fraction (where the majority
of this protein may be found), Af challenge of sensitized
C57BL/6 mice induced a 1,894 ± 170% increase in SP-D
from the naïve control group, that was 1.5 fold greater
than the 1,269 ± 142% increase in Balb/c mice (p < 0.01
Figure 4A and 4B). In addition, SP-D expression was also
significantly greater in naïve C57BL/6 mice (SA BAL SP-D
levels were 233% of naïve Balb/c SP-D levels p < 0.05).
Thus, sensitization and challenge with Af  markedly
increased SP-D protein content in the SA BAL fraction of
both Balb/c and C57BL/6 mice, however the latter show a
distinctly greater capability to produce SP-D in response
to allergen challenge. The fact that SP-D expression was
also significantly greater in naïve C57BL/6 mice than in
Balb/c mice suggests that baseline production of this col-
lectin in the lung is genetically determined.
SP-D increase following Af-challenge of sensitized mice 
was selective in both C57BL/6 and Balb/c mice
To study whether the increases in SP-D levels correlated
with total mRNA levels, we also analyzed SP-D mRNA
expression. Although there was a trend towards increases
in SP-D mRNA following sensitization and challenge in
C57BL/6 mice (184% of non-sensitized control SP-D
mRNA), the findings were not statistically significant (Fig-
ure 4C and 4D) indicating that a possibly enhanced
mRNA transcription may not be the sole requirement for
allergic inflammation induced SP-D production. Since
Table 1: C57BL/6 mice showed significantly heightened BAL protein levels and inflammatory changes in the BAL phospholipid profile 
in comparison with Balb/c mice following allergic sensitization and challenge with Af.
MOUSE STRAIN Protein, µg per lung Phospholipid, µg per lung
LA SA LA SA
BALB/C Naive 94 ± 19 1,075 ± 154 144 ± 25 78 ± 11
Sensitized 99 ± 14 1,059 ± 108 146 ± 12 106 ± 14
C57BL/6 Naive 56 ± 6 1,283 ± 200 148 ± 22 97 ± 6
Sensitized 56 ± 7 1,998 ± 266*# 100 ± 12* 146 ± 24*
Protein and phospholipid content were analyzed from the large aggregate (LA) and the small aggregate (SA) surfactant fractions of naïve and 
sensitized mice as described. Data are expressed as amount of protein or phospholipid (micrograms) per mouse lung. Mean ± SEM of n = 16–22 
mice per group were calculated after deriving the average of the results from two independent experiments. *p < 0.05 Sensitized vs Naive; #p < 
0.05 C57BL/6 vs Balb/c.Respiratory Research 2003, 4 http://respiratory-research.com/content/4/1/15
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changes in mRNA expression were not proportional to
those in protein expression (an approximately two fold
increase in SP-D mRNA accompanied a nearly 20 fold
enhancement in SP-D protein), we speculate that in addi-
tion to transcriptional regulation, metabolism of this lung
collectin may also be significantly affected during allergic
inflammation and a reduced recycling or an increased half
life may contribute to its accumulation [30].
To confirm the selectivity of SP-D upregulation in C57BL/
6 mice during allergic airway inflammation we also
analyzed the LA and SA surfactant fractions for SP-A, the
other member of the hydrophilic surfactant protein (lung
Following allergic challenge of sensitized C57BL/6 mice there was a significantly increased production of SP-D in the lung in  comparison with similarly treated Balb/c mice Figure 4
Following allergic challenge of sensitized C57BL/6 mice there was a significantly increased production of SP-D 
in the lung in comparison with similarly treated Balb/c mice. Western blot of three representative SP-D samples from 
the SA surfactant fraction of the BAL fluid of Balb/c and C57BL/6 mice (A). Nitrocellulose blots with samples of SA surfactant 
from BAL naïve and sensitized mice were probed with polyclonal antisera against SP-D antibody as described. Each lane con-
tains 10 µg total protein. The relative content of SP-D bands in each sample was determined by densitometric scanning of the 
43-kD bands from multiple blots and quantified as described (B). Open bars: Naive mice; Closed bars: Sensitized mice. Data are 
expressed as % of naïve controls levels. N = 3–5 samples were used in each group. Mean ± SEM was calculated after deriving 
the average of the results from two independent experiments. *p < 0.05 Sensitized vs Naive; #p < 0.05 C57BL/6 vs Balb/c. 
Autoradiographs of three representative SP-D mRNA samples of Balb/c and C57BL/6 mice (C). Total RNA for northern blot 
analysis was prepared from the lungs of naïve and sensitized mice as described. Intensity was quantified by densitometric scan-
ning and values were normalized to 28S mRNA (D). Intensity of 28S band was similar in each sample (data not shown). SP-D 
mRNA content is expressed as % of naïve Balb/c level. Open bars: Naive mice; Closed bars: Sensitized mice. N = 7–8 samples 
were used. Mean ± SEM was calculated after deriving the average of the results from two independent experiments.
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collectin) family. SP-A protein (Fig 5A and 5B) and mRNA
(Fig 5C) levels were unaffected by allergic sensitization
and challenge in C57BL/6 and Balb/c mice as demon-
strated by Western blot analysis of both the LA and SA
surfactant fractions (Fig 5A) and Northern blot analysis of
the lung tissue (Fig 5C). Further, naïve C57BL/6 mice had
significantly lower levels of SP-A protein when compared
with Balb/c mice by ELISA (Fig 5B) and Western blot (Fig
5A).
In addition to the hydrophilic surfactant proteins, we
studied changes in the hydrophobic SP-B and SP-C.
SP-A protein levels in the lung of C57BL/6 mice were not increased following allergic challenge of sensitized mice Figure 5
SP-A protein levels in the lung of C57BL/6 mice were not increased following allergic challenge of sensitized 
mice. Western blot of three representative SP-A samples from the LA surfactant fraction of the BAL fluid of Balb/c and 
C57BL/6 mice (A). Nitrocellulose blots with samples of LA surfactant from naïve and sensitized mice were probed with poly-
clonal anti-SP-A antibody as described. Each lane contains 5 µg total protein. The relative content of SP-A doublet bands in 
each sample was determined by densitometric scanning of the 29–35 kD bands from multiple blots and quantified as described 
(B). Open bars: Naive mice; Closed bars: Sensitized mice. Data are expressed as % of naïve Balb/c levels. Mean ± SEM of n = 3–
5 was calculated after deriving the average of the results from two independent experiments. # p < 0.05 C57BL/6 vs naïve Balb/
c mice. The SP-A content in the LA and SA fractions of naïve mice was also determined by using an ELISA protocol as 
described. Total BAL SP-A content (C) was expressed as total ng. Gray bars: LA fraction of BAL; Black bars: SA fractions of 
BAL. Data are expressed as Mean ± SEM of n = 5 samples in each group. #p < 0.05 C57BL/6 vs naïve Balb/c mice. Total RNA 
for northern blot analysis was prepared from the lungs of naïve and sensitized mice as described. Intensity was quantified by 
densitometric scanning and values were normalized to 28S mRNA (D). SP-A mRNA contents are expressed as % of naïve Balb/
c level. Open bars: Naive mice; Closed bars: Sensitized mice. Mean ± SEM of n = 3–5 samples was calculated after deriving the 
average of the results from two independent experiments.
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Western blot analysis of the LA aggregate fraction (where
SP-B and SP-C are found) demonstrated a 50% reduction
of sensitized Balb/c and C57BL/6 mice (data not shown).
Although reduction of the hydrophobic surfactant pro-
teins was similar between strains, C57BL/6 mice had
slightly lower baseline levels of SP-B when compared with
naïve Balb/c mice (30 ± 12% of naïve Balb/c level). Thus,
the only surfactant protein that showed significant
increases during allergic airway inflammation was SP-D.
Regression analysis between SP-D and airway eosi-
nophilia showed a statistically significant positive correla-
tion (r = 0.7305, p < 0.05) indicating that greater
inflammation elicits the production of more SP-D in the
lung.
The mechanisms that may be responsible for enhanced
production of SP-D in the lung are unknown. Positive cor-
relations between SP-D levels and airway eosinophilia
may indicate a potential common regulatory pathway. In
support of that, recent studies in mice over expressing IL-
4 [30,31], IL-5 [32] and IL-13 [33] in the lung tissue indi-
cated that Th2-type inflammation induced over produc-
tion of SP-D. Enhanced SP-D expression in return may
exert a protective immunosuppressive function in the dis-
tal airspaces. Originally SP-D was thought to be important
in stimulating clearance of pathogens and allergenic
material by macrophages, providing a first line of protec-
tion from allergic sensitization [13,34]. Later this collectin
was shown to inhibit lymphocyte proliferation and
decrease histamine release by basophils induced by house
Allergen challenge of sensitized C57BL/6 mice induced impaired IL-4 and IL-5 release in comparison with Balb/c mice Figure 6
Allergen challenge of sensitized C57BL/6 mice induced impaired IL-4 and IL-5 release in comparison with Balb/
c mice. Cytokine levels in BAL were determined by ELISA. Data are expressed as pg per µg of protein level. The Naïve group 
(open bar, Balb/c (n = 9) or light gray bar, C57BL/6 (n = 9)) received intranasal glycerol treatment alone. The Sensitized group 
(black bar, Balb/c (n = 12) or dark gray bar, C57BL/6 (n = 12)) received i.p. sensitization and i.n. treatment with Af extract. 
Data are expressed as Mean ± SEM, *p < 0.05 Sensitized vs Naive; #p < 0.05 C57BL/6 vs Balb/c.
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dust mite and Af allergens [34]. In recent murine models
of allergic bronchopulmonary aspergillosis (ABPA), SP-D
treatment protected against mortality and inhibited the
immunoglobulin, eosinophil and Th2 cytokines associ-
ated with this model of fungal infection [35,36].
Th2 cytokine levels in the BAL fluid of C57BL/6 mice were 
inhibited in comparison with Balb/c mice following 
sensitization and challenge with Af
Aside from processes such as maturation, recruitment and
survival of eosinophilic granulocytes, that are ultimately
reflected by the numbers of these cells observed in the
lung tissue, the ability to release de novo synthesized and
preformed proinflammatory mediators is also essential to
mount an inflammatory response [11]. This effector func-
tion is dependent on optimal priming and activation of
these cells by eosinophil active Th2-type cytokines includ-
ing IL-3, IL-5, IL-9 and GM-CSF [37,38]. To that end, it is
of interest that analyses of the murine IL-9 gene identified
a genetic defect at the IL-9 locus in C57BL/6 mice [2]. To
investigate the association of BAL SP-D levels with the
cytokine profile induced by allergenic sensitization and
challenges in Balb/c and C57BL/6 mice, we analyzed IFN-
γ, TNF-α, IL-4 and IL-5 protein expression in the BAL
supernatant. Similarly to our earlier studies, sensitization
and challenge with Af markedly enhanced IL-4 and IL-5.
IFN-γ decreased by approximately 50% in both strains;
from 143 ± 20 to 67 ± 6 pg/ng of total protein in Balb/c
mice and from 79 ± 10 to 36 ± 5 pg/ng of total protein in
C57BL/6 mice. As shown in Figure 6, IL-4 and IL-5 were
increased in mice sensitized and challenged with Af in
comparison with naïve controls both in the Balb/c and the
C57BL/6 strains (p < 0.05). The increase in cytokine levels
in the C57BL/6 mice however, was significantly attenu-
ated following sensitization and challenge with Af in com-
parison with Balb/c mice suggesting local inhibition of
release or synthesis of these cytokines. Thus, sensitization
and challenge with Af markedly enhanced IL-4 and IL-5
but not IFN-γ both in the Balb/c and the C57BL/6 strains
as also shown in our previous studies [12,16,17]. The
increase in the Th2 cytokine levels in the C57BL/6 mice
was however, significantly attenuated suggesting inhibi-
tion of release or reduced synthesis.
Conclusions
In conclusion, SP-D production was increased in response
to allergic airway inflammation in mice sensitized and
challenged with Af. This process may be genetically regu-
lated and may serve a negative feedback that would
inhibit further Th2 activation. We speculate that enhanced
SP-D levels may be responsible for an impaired ability of
C57BL/6 mice to develop allergen induced AHR.
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